Pulse actinomycin-D [dactinomycin] as salvage therapy for failed low risk gestational trophoblastic neoplasia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dactinomycin (Primary)
- Indications Trophoblastic tumour
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2013 Biomarkers information updated
- 06 Aug 2007 Status changed from in progress to completed.
- 17 Sep 2005 New trial record.